Lindbrook Capital’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $6.92K | Buy |
143
+77
| +117% | +$3.72K | ﹤0.01% | 1814 |
|
|
2024
Q4 | $2.55K | Sell |
66
-10
| -13% | -$386 | ﹤0.01% | 2230 |
|
|
2024
Q3 | $3.42K | Buy |
76
+27
| +55% | +$1.22K | ﹤0.01% | 2165 |
|
|
2024
Q2 | $1.7K | Sell |
49
-124
| -72% | -$4.3K | ﹤0.01% | 2395 |
|
|
2024
Q1 | $5.01K | Buy |
+173
| New | +$5.01K | ﹤0.01% | 1890 |
|
|
2022
Q3 | – | Sell |
-26
| Closed | – | – | 2873 |
|
|
2022
Q2 | $0 | Buy |
+26
| New | – | ﹤0.01% | 2734 |
|
|
2021
Q4 | – | Sell |
-2,450
| Closed | -$43K | – | 2188 |
|
|
2021
Q3 | $43K | Buy |
2,450
+2,000
| +444% | +$35.1K | 0.01% | 482 |
|
|
2021
Q2 | $20K | Sell |
450
-2,750
| -86% | -$122K | ﹤0.01% | 784 |
|
|
2021
Q1 | $83K | Buy |
3,200
+2,000
| +167% | +$51.9K | 0.02% | 307 |
|
|
2020
Q4 | $24K | Buy |
1,200
+1,000
| +500% | +$20K | 0.01% | 620 |
|
|
2020
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 1195 |
|
|
2020
Q2 | $4K | Sell |
200
-1,300
| -87% | -$26K | ﹤0.01% | 1192 |
|
|
2020
Q1 | $11K | Buy |
+1,500
| New | +$11K | ﹤0.01% | 731 |
|